NCT07198139View on ClinicalTrials.gov

A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

October 1, 2026

Conditions
Norovirus
Interventions
DRUG

CDI-988

Antiviral to treat norovirus

DRUG

Placebo

Matching placebo

OTHER

Snow Mountain Virus

Challenge with Snow Mountain Virus

Trial Locations (1)

30030

Hope Clinic of the Emory Vaccine Center, Decatur

Sponsors
All Listed Sponsors
lead

Cocrystal Pharma, Inc.

INDUSTRY

NCT07198139 - A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CDI-988 in Healthy Adults After Challenge With Snow Mountain Virus | Biotech Hunter | Biotech Hunter